CD200 as a prognostic factor in acute myeloid leukaemia.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 17252007)

Published in Leukemia on January 25, 2007

Authors

A Tonks, R Hills, P White, B Rosie, K I Mills, A K Burnett, R L Darley

Articles citing this

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol (2009) 2.78

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood (2008) 2.63

Programmed cell removal: a new obstacle in the road to developing cancer. Nat Rev Cancer (2011) 1.84

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood (2012) 1.77

Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma. Am J Clin Pathol (2012) 1.57

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood (2010) 1.49

CD200 is induced by ERK and is a potential therapeutic target in melanoma. J Clin Invest (2007) 1.45

Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc (2009) 1.25

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood (2011) 1.16

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma. Cancer Res (2010) 1.14

Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J Immunol (2009) 1.13

Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia. Blood (2011) 1.12

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia (2011) 1.07

Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. J Immunol (2010) 1.04

Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy. Eur J Immunol (2010) 1.00

Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions. PLoS One (2012) 0.99

Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure (2013) 0.95

CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog (2012) 0.92

Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells. Leukemia (2012) 0.91

Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia. Proc Natl Acad Sci U S A (2012) 0.91

CD200-expressing human basal cell carcinoma cells initiate tumor growth. Proc Natl Acad Sci U S A (2013) 0.90

Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling. Breast Cancer Res Treat (2013) 0.89

Expression of CD200 on AML blasts directly suppresses memory T-cell function. Leukemia (2012) 0.86

Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200. J Virol (2012) 0.86

The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection. J Virol (2014) 0.84

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse. Leukemia (2015) 0.81

Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy. Mol Oncol (2015) 0.79

Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy. PLoS One (2014) 0.79

Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors. Polymers (Basel) (2014) 0.78

A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. PLoS One (2014) 0.78

Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF. Nucleic Acids Res (2010) 0.78

CD200: association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma. Head Neck (2014) 0.78

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia. J Transl Med (2015) 0.76

Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors. Oncotarget (2015) 0.76

Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia. Oncotarget (2016) 0.76

The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia. Indian J Hematol Blood Transfus (2014) 0.75

A Truncated form of CD200 (CD200S) Expressed on Glioma Cells Prolonged Survival in a Rat Glioma Model by Induction of a Dendritic Cell-Like Phenotype in Tumor-Associated Macrophages. Neoplasia (2016) 0.75

A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. J Immunol (2016) 0.75

Immunomodulatory drugs II: Immune Checkpoint Agents in Acute Leukemia. Curr Drug Targets (2015) 0.75

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy. Immunotherapy (2016) 0.75

Articles by these authors

General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ (1998) 13.39

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood (2001) 5.34

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood (2001) 5.20

Ethnic differences in consultation rates in urban general practice. BMJ (1989) 4.61

Medicine must change to serve an ageing society. Eradicate age discrimination and increase resources. BMJ (1999) 3.43

Psychological and social adjustment to mastectomy: a two-year follow-up study. Cancer (1977) 3.36

The role of letters in reviewing research. BMJ (1994) 3.26

Stopping smoking after myocardial infarction. Lancet (1974) 2.87

The effect of hand dominance on recurrent idiopathic paediatric epistaxis. Clin Otolaryngol (2008) 2.83

Uncoupling cadherin-based adhesion from wingless signalling in Drosophila. Nature (1996) 2.76

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain (1976) 2.76

Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis (2009) 2.68

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61

Pregnancy's toll in the developing world. BMJ (1994) 2.50

Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med (1999) 2.47

Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun (1996) 2.44

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol (1999) 2.24

Amplification of mitochondrial DNA in acute myeloid leukaemia. Br J Haematol (1996) 2.17

Cigarette advertising policy and coverage of smoking and health in British women's magazines. Lancet (1991) 2.09

Investigation and management of pulmonary infiltrates following bone marrow transplantation: an eight year review. Thorax (1993) 2.08

Reviewers chosen by authors. BMJ (1995) 2.05

FEV1 and PEF in COPD management. Thorax (1999) 1.88

Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J (2000) 1.86

Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones. Gut (1994) 1.83

Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc (1995) 1.77

Survival, morbidity, and quality of life after discharge from intensive care. Crit Care Med (2000) 1.75

Controlled comparison of short-wave diathermy treatment with osteopathic treatment in non-specific low back pain. Lancet (1985) 1.74

Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood (1997) 1.73

Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72

Diabetes mellitus in pregnancy. Clin Perinatol (1974) 1.72

Dielectrophoretic separation and enrichment of CD34+ cell subpopulation from bone marrow and peripheral blood stem cells. Med Biol Eng Comput (1995) 1.68

Neocortical cholinergic neurons in elderly people. Lancet (1977) 1.68

Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood (1999) 1.68

PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist (1997) 1.67

The dielectrophoresis enrichment of CD34+ cells from peripheral blood stem cell harvests. Bone Marrow Transplant (1996) 1.65

Chronic pancreatitis: a complication of systemic lupus erythematosus. Gastroenterology (1993) 1.65

Honey stimulates inflammatory cytokine production from monocytes. Cytokine (2003) 1.63

Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol (1994) 1.63

Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. Lancet Neurol (2008) 1.62

Allele loss from chromosome 17 in ovarian cancer. Oncogene (1990) 1.60

Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial. Br J Haematol (2001) 1.58

Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation (1999) 1.53

Information management and patient privacy in the NHS. BMJ (1993) 1.51

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia (2008) 1.50

Biochemical and genetic characterization of nirB mutants of Escherichia coli K 12 pleiotropically defective in nitrite and sulphite reduction. J Gen Microbiol (1980) 1.45

Combined pedunculopontine-subthalamic stimulation in Parkinson disease. Neurology (2012) 1.45

Postoperative reparalysis after rocuronium following nebulized epinephrine. Can J Anaesth (1997) 1.44

Revised guidelines for HIV infected health workers. BMJ (1993) 1.43

Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Fail (2002) 1.40

Third party mediated graft rejection despite irradiation of blood products. Br J Haematol (1992) 1.39

Transplantation in first remission of acute myeloid leukemia. N Engl J Med (1998) 1.39

Tumour-like calcinosis causing reversible tetraparesis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2001) 1.38

Quantitative estimates of soil ingestion in normal children between the ages of 2 and 7 years: population-based estimates using aluminum, silicon, and titanium as soil tracer elements. Arch Environ Health (1990) 1.37

Effect of dextran and ammonium sulphate on the reaction catalysed by a glucosyltransferase complex from Streptococcus mutans. J Gen Microbiol (1980) 1.33

Nicotinic acid adenine dinucleotide phosphate triggers Ca2+ release from brain microsomes. Curr Biol (1999) 1.32

Evidence for synergy between family 2b carbohydrate binding modules in Cellulomonas fimi xylanase 11A. Biochemistry (2001) 1.31

The potent bone-resorbing mediator of Actinobacillus actinomycetemcomitans is homologous to the molecular chaperone GroEL. J Clin Invest (1995) 1.30

Epidemiology and control of egg-associated Salmonella enteritidis in the United States of America. Rev Sci Tech (1997) 1.29

Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia (2007) 1.29

Relationship between psychosocial factors and asthma morbidity. Fam Pract (1988) 1.29

Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol (2000) 1.28

Erectile function after anterior urethroplasty. J Urol (2001) 1.26

Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol (1998) 1.26

Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol (1999) 1.26

Three-dimensional CT-guided bronchoscopy with a real-time electromagnetic position sensor: a comparison of two image registration methods. Chest (2000) 1.25

The differentiation of Chlamydia species by antigen detection in sputum specimens from patients with community-acquired acute respiratory infections. J Infect (1992) 1.25

How infectious is syphilis? Br J Vener Dis (1983) 1.24

Alleles at D6S265 and D6S105 define a haemochromatosis-specific genotype. Br J Haematol (1994) 1.23

Best evidence: comments on meta-analysis of coiling versus clipping. AJNR Am J Neuroradiol (2013) 1.22

Schizophrenics have fewer and smaller P300s: a single-trial analysis. Biol Psychiatry (1994) 1.21

Perception and recognition of normal and negative faces: the role of shape from shading and pigmentation cues. Perception (1996) 1.21

Laparoscopic salvage of malfunctioning peritoneal catheters. Surg Endosc (1997) 1.21

Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.19

An ethics committee for the BMJ. BMJ (2000) 1.19

BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents. Oncogene (2001) 1.18

A novel carbohydrate-binding protein is a component of the plant cell wall-degrading complex of Piromyces equi. J Biol Chem (2001) 1.18

Access to and use of out-of-hours services by members of Vietnamese community groups in South London: a focus group study. Fam Pract (1999) 1.17

A 5.8-kDa component of manuka honey stimulates immune cells via TLR4. J Leukoc Biol (2007) 1.17

Utility of the Determine Syphilis TP rapid test in commercial sex venues in Peru. Sex Transm Infect (2006) 1.16

Brain-decarboxylase activities as indices of pathological change in senile dementia. Lancet (1974) 1.16

GPs' views of discussions of prognosis in severe COPD. Fam Pract (2001) 1.14

Bristol COPD Knowledge Questionnaire (BCKQ): testing what we teach patients about COPD. Chron Respir Dis (2006) 1.14

Selective vulnerability of neurones in organic dementia. Nature (1977) 1.14

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia. Leukemia (2012) 1.14

Predicting psychiatric admission rates. BMJ (1992) 1.13

The production of carbon monoxide from hemoglobin in vivo. J Clin Invest (1967) 1.12

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett (1983) 1.12

Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells. J Exp Med (1997) 1.11

Attitudes towards practice nurses--survey of a sample of general practitioners in England and Wales. Br J Gen Pract (1993) 1.11

Distribution of leukemia, lymphoma, and allied disease in parts of Great Britain: analysis by administrative districts and simulations of adjacencies. Leukaemia Research Fund 1984 Data Collection Group. Leukemia (1987) 1.11

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party. Br J Haematol (1997) 1.10

The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system. Br J Cancer (1998) 1.09